The Synuclein 2025 Meeting Committee invites companies and organisations to help support this key international event through participation as an exhibitor, sponsor or supporter in Cambridge, in April 2025.
300 are expected to attend and the programme will include sessions on the physiology, structure and pathology of alpha-synuclein as well as the development of therapeutics and biomarkers for alpha-synucleinopathies.
The meeting, across 4 days, will provide a perfect opportunity to discuss the latest developments in the field from fundamental discoveries to translational studies, similar to meetings previously held in Leuven (Synuclein 2022), Lisbon (Synuclein 2019) and Athens (2017).
For more information, please download an overview of the opportunities here.
Please contact Rose Padmore syn25@opening-doors.org.uk for more information
+44 (0) 1562 731788
Managed by appointed conference organisers
Opening Doors & Venues Ltd